Argenx
ARGX
#422
Rank
โ‚น5.045 T
Marketcap
โ‚น81,012
Share price
-1.62%
Change (1 day)
56.60%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2025 (TTM): โ‚น776.72

According to Argenx 's latest financial reports the company's current EPS (TTM) is โ‚น797.38. In 2024 the company made an earnings per share (EPS) of โ‚น1,251 an increase over its 2023 EPS that were of -โ‚น463.86.

EPS history for Argenx from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น776.72-37.93%
2024โ‚น1,251-369.77%
2023-โ‚น463.86-60.46%
2022-โ‚น1,17363.33%
2021-โ‚น718.27-40.37%
2020-โ‚น1,205183.47%
2019-โ‚น424.95123.09%
2018-โ‚น190.4954.93%
2017-โ‚น122.9514.07%
2016-โ‚น107.7813.05%
2015-โ‚น95.33-36.34%
2014-โ‚น149.76209.04%
2013-โ‚น48.46-33.99%
2012-โ‚น73.41185.59%
2011-โ‚น25.71